Professional development Vacancies

Yesterday, 20 July, the Center held another weekly meeting of the Center’s Director Mykhailo Babenko and his deputies M.V. Lobas and Ye.V. Tkachenko with the heads of the Center’s structural units

22.07.2021 Updated 01.04.2022 1663 views

This time almost 20 managers took part in the meeting. First, M. M. Babenko briefly addressed the implementation of the decisions adopted at the previous meeting. Following the discussion, it was agreed:

  • Refine the placement of some employees at the address: Antona Tsedika Street.14, to improve working conditions on Smolenska Street, 10;
  • Continue working in the “Pharmacodecision” system on the products that are in an outdated status;
  • Jointly with the heads of laboratories, hold a meeting on issues of improving performance.

Next, the heads reported to management on the state of affairs in the format of problematic issues. Among those requiring further work:

  • Continue work on amending the MoH order of 26.08.2005 No. 426 (as revised on 23.07.2015 No. 460);
  • Complete the development of the procedure for advance payment for services for clinical trials;
  • To adopt the final version of the proposed amendments to MoH order of April 10, 2013 No. 292 “On Modernizing the Operation of the Telephone ‘Hotline’ System of the Ministry of Health of Ukraine” concerning an increase in the number of staff, if necessary;
  • Hold a meeting of the Director of the Center with specialists of the Division for Development and Operation of Information Systems and Telecommunication Networks and specialists of the HTA Department on matters of the State Register of Medicinal Products;
  • Update the regulatory framework for the Center's interaction with the State Service of Ukraine on Medicinal Products and Drugs Control;
  • Complete the development of amendments to instruction No. 39 of 28.02.2019 “Procedure for the Passage of Documents in the Communication Coordination Unit of the External Communications Directorate of the Department of Coordination of Expert Materials” and the development of a procedure for prepayment of the cost of services for clinical trials;
  • To submit proposals for amendments to MoH orders No. 690 and No. 944 with a view to further improving the conduct of clinical trials and preclinical studies of medicinal products, for their subsequent submission to the MoH.
  • Agree with the developers on the option of transferring vaccine data for COVID certificates.